CoronaryEditorial CommentDrug-Eluting Stent Choice in Patients With Acute Myocardial Infarction∗
Corresponding Author
Key Words
Cited by (0)
Dr. Windecker has received research and educational grants to the institution from Abbott, Amgen, Bayer, Bristol-Myers Squibb, Boston Scientific, Biotronik, CSL Behring, Edwards Lifesciences, Medtronic, Polares, and Sinomed. Dr. Pilgrim has received research grants to the institution from Biotronik, Symetis/Boston Scientific, and Edwards Lifesciences; has received speaking fees from Biotronik and Boston Scientific; and is a consultant for HighLife SAS. Dr. Ueki has reported that he has no relationships relevant to the contents of this paper to disclose.
- ∗
Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.